GHCM
BSX icon

Glen Harbor Capital Management’s Boston Scientific BSX Stock Holding History

Glen Harbor Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$4.68M Sell
114,954
-33,048
-22% -$1.4M 0.1% 198
2019
Q2 		$6.36M Buy
148,002
+73,950
+100% +$2.84M 0.13% 158
2019
Q1 		$2.84M Buy
74,052
+4,046
+6% +$155K 0.06% 264
2018
Q4 		$2.47M Buy
70,006
+20,570
+42% +$746K 0.06% 273
2018
Q3 		$1.9M Sell
49,436
-3,604
-7% -$126K 0.04% 343
2018
Q2 		$1.74M Buy
53,040
+2,108
+4% +$63.6K 0.04% 338
2018
Q1 		$1.39M Sell
50,932
-13,022
-20% -$354K 0.03% 349
2017
Q4 		$1.58M Sell
63,954
-11,118
-15% -$307K 0.04% 340
2017
Q3 		$2.19M Sell
75,072
-153,034
-67% -$4.23M 0.05% 280
2017
Q2 		$6.32M Sell
228,106
-124,746
-35% -$3.31M 0.15% 131
2017
Q1 		$8.78M Sell
352,852
-51,000
-13% -$1.24M 0.22% 85
2016
Q4 		$8.73M Buy
+403,852
New +$8.81M 0.24% 77

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Glen Harbor Capital Management's BSX Position: Q3 2019 in Review

Glen Harbor Capital Management reduced its Boston Scientific (BSX) stake by 22% in Q3 2019, selling an estimated $1.4M and leaving 114,954 shares worth $4.68M. The position accounts for 0.1% of the portfolio, ranked #198.

Glen Harbor Capital Management first reported a position in BSX in Q4 2016 and has held it in 12 quarters since. The position peaked at $8.78M in Q1 2017. 771 funds tracked by Wall St. Rank hold BSX as of Q3 2019.

  • Glen Harbor Capital Management held 114,954 shares of Boston Scientific worth $4.68M as of Q3 2019.
  • Glen Harbor Capital Management sold 33,048 Boston Scientific shares in Q3 2019, an estimated $1.4M.
  • Boston Scientific made up 0.1% of Glen Harbor Capital Management's portfolio in Q3 2019, its #198 holding.
  • Glen Harbor Capital Management first reported a position in Boston Scientific in Q4 2016 and has held it in 12 quarters since.
  • Glen Harbor Capital Management's Boston Scientific position peaked at $8.78M in Q1 2017.
  • 771 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.